PERSONAL INFORMATION
Nationality | Syrian |
Date of Birth | 01-11-1986 |
EMPLOYMENT HISTORY
2016-2018 | Research Scientist, Rohto Pharmaceutics, Kyoto, Japan |
2014-2015 | Teacher Assistant, Sagano High School, Kyoto, Japan |
EDUCATION
2013-2016 | Kyoto University, Graduate School of Pharmaceutical Sciences, Kyoto, Japan
PhD: PhD in Pharmaceutical Sciences |
2011-2013 | Kyoto University, Graduate School of Pharmaceutical Sciences, Kyoto, Japan
MSc: Master in Pharmaceutical Sciences |
2004-2009 | Damascus University, College of Pharmacy, Damascus, Syria
BSc: Bachelor Degree in Pharmacy and Pharmaceutical Chemistry |
LANGUAGES
Kurdish (Native level) | Arabic (Native level) |
English (Fluent level) | Japanese (Upper intermediate level) |
HOBBIES
Music (violin), Basketball, and Painting |
PUBLICATIONS
PhD Thesis
|
Rodi Abdalkader. Development of novel phospholipids-based ultrasound contrast agents intended for drug delivery and cancer theranostics. Doctoral Thesis. Kyoto University, 2016 |
Peer Review Journal
|
Rodi Abdalkader, Shigeru Kawakami, Johan Unga, Ryo Suzuki, Kazuo Maruyama, Fumiyoshi Yamashita, and Mitsuru Hashida. Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumor model (2015). Acta Biomaterialia19, 112-118 Rodi Abdalkader, Shigeru Kawakami, Johan Unga, Yuriko Higuchi, Ryo Suzuki, Kazuo Maruyama, Fumiyoshi Yamashita & Mitsuru Hashida. The development of mechanically formed stable nanobubbles intended for sonoporation-mediated gene transfection (2017). Drug Delivery, 24:1, 320-327 |
Book Chapters
|
Rodi Abdalkaderand Mitsuru Hashida. Focused ultrasound ablation enhancement of specific antitumor immunity (Book title: Image-guided Focused Ultrasound Therapy: Physics and Clinical Applications, by CRC press Taylor & Francis group). CRC Press LLC, 2018. ISBN 149871135 |
Conferences & Academic Meetings
Ultrasound triggered doxorubicin loaded microbubbles for effective therapeutic outcomes in melanoma. Presentation: 72nd Annual meeting of the Japanese Cancer Association. Yokohama, October 3-5 (2013) Theranostic doxorubicin loaded microbubbles as a novel approach in cancer. Poster: UK-Japan workshop on inorganic framework material. Kyoto, October 10-11 (2013). Ultrasound triggered doxorubicin loaded microbubbles as a novel approach in cancer. Presentation: 29th Annual meeting of Japanese Academy of Pharmaceutical Sciences and Technology. Saitama, May 20-22 (2014) Ultrasound triggered doxorubicin loaded microbubbles: a novel strategy toward more effective therapeutic outcomes in cancer. Poster: FIP congress in PSWC. Melbourne (Australia). April 13-16 (2014) Phospholipids-based doxorubicin loaded microbubbles as a novel tumour theranostic agent. Presentation: The 8th Seoul-Kyoto-Osaka joint symposium on pharmaceutical sciences for young scientists. Osaka, June 10-11(2014) The formation of doxorubicin loaded microbubbles and their role in tumour theranostics. Poster: iCeMS International Symposium. Hierarchical Dynamics in Soft Material and Biological matter. Kyoto, Sept. 23-26 (2015) The Development of phase shift acoustic nanodroplets (PSANDs) and their potential use in ultrasound Theranostics. Poster: The 12th congress of the Asian Federation of Societies for Ultrasound in Medicine and Biology. Kyoto, May 27-29 (2016) The formulation and evaluation of nano-sized bubbles for sustainable gene expression in mice limb muscles. Poster: The 1st Workshop for Japan-Korea Young Scientists on pharmaceutical sciences. Kyoto, June 24-25 (2016) The effect of pluronic F127 on enhancing retinol palmitate delivery in human corneal epithelial cells. E-Poster: World Ophthalmology Congress of the International Council of Ophthalmology. Barcelona, Spain, June 16-19 (2018) |
FUNDS & AWARDS
The Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT) Global Education Seminar Award from the Academy of Pharmaceutical Sciences and Technology, Japan |